StockWatch
·
Major Chemicals
Quarterly ResultAug 5, 2026, 04:31 PM

Albemarle Q2 Net Sales $1.7B, Up 31%; Net Income $480M

AI Summary

Albemarle Corporation reported strong second-quarter 2026 results, with net sales climbing 31% to $1.7 billion and net income surging to $480 million. The growth was primarily fueled by higher pricing in Energy Storage and increased pricing and volumes in Specialties. The company also improved its full-year 2026 outlook for Specialties net sales and adjusted EBITDA, while reducing its capital expenditure forecast, reflecting disciplined cost management and robust market demand.

Key Highlights

  • Net sales for Q2 2026 reached $1.7 billion, marking a 31% increase year-over-year.
  • Net income attributable to common shareholders was $480 million, or $3.52 per diluted share, up 1,996.2% year-over-year.
  • Adjusted EBITDA increased by 155% to $858 million, driven by higher pricing in Energy Storage and Specialties.
  • Energy Storage net sales grew 78% to $1.3 billion, with Adjusted EBITDA up 229.3% to $723.5 million.
  • Specialties net sales rose 20% to $423.5 million, and Adjusted EBITDA increased 61% to $117.7 million.
  • Full-year 2026 Specialties net sales outlook increased to $1.4-$1.6 billion, with adjusted EBITDA outlook raised to $275-$325 million.
  • Full-year capital expenditure forecast reduced to approximately $500 million due to efficiency improvements.
  • Achieved $100 million in year-to-date run-rate cost and productivity improvements.